跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION
Orpha-Devel Handels Und Vertriebs Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 21, 2024
Approval ID
29df93f751f26433
Company
Orpha-Devel Handels Und Vertriebs Gmbh
Type
Standard
Approval Details
Approval Id
29df93f751f26433
Drug Cima Aemps Name
RAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSION
Register Number
89271
Holder Company Name
Orpha-Devel Handels Und Vertriebs Gmbh
Marketing Company Name
Aop Orphan Pharmaceuticals Iberia, S.L.U
Authorization Date
2024-02-21
Dosage Form
POLVO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
300 mg
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Orpha-Devel Handels Und Vertriebs Gmbh
Active Ingredients
LANDIOLOL HIDROCLORURO
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 21, 2024
Approval ID
29df93f751f26433
Type
Standard
Back to CIMA-AEMPS Approvals
